These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20056331)

  • 1. Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.
    Espino AM; Rivera F
    Vet Parasitol; 2010 Apr; 169(1-2):82-92. PubMed ID: 20056331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.
    Espino AM; Morales A; Delgado B; Rivera FM; Figueroa O; Suárez E
    Ethn Dis; 2010; 20(1 Suppl 1):S1-17-23. PubMed ID: 20521379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
    Rivera F; Espino AM
    Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential.
    Espino AM; Hillyer GV
    J Parasitol; 2004 Aug; 90(4):876-9. PubMed ID: 15357089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax Gold® adjuvant against experimental fasciolosis in rats.
    Henker LC; Schwertz CI; Lucca NJ; Piva MM; Prior KC; Baska P; Norbury L; Januszkiewicz K; Dezen D; Duarte MMMF; Moresco RN; Bertagnolli da Rosa L; Mendes RE
    Vaccine; 2017 Jan; 35(4):663-671. PubMed ID: 28024953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
    Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin 4, interleukin 4 splice variants and interferon gamma mRNA in calves experimentally infected with Fasciola hepatica.
    Waldvogel AS; Lepage MF; Zakher A; Reichel MP; Eicher R; Heussler VT
    Vet Immunol Immunopathol; 2004 Jan; 97(1-2):53-63. PubMed ID: 14700537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
    Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
    Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.
    Rojas-Caraballo J; López-Abán J; Pérez del Villar L; Vizcaíno C; Vicente B; Fernández-Soto P; del Olmo E; Patarroyo MA; Muro A
    PLoS One; 2014; 9(8):e105323. PubMed ID: 25122166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice.
    Espino AM; Osuna A; Gil R; Hillyer GV
    Exp Parasitol; 2005 Aug; 110(4):374-83. PubMed ID: 15907838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
    Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
    Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1).
    Golden O; Flynn RJ; Read C; Sekiya M; Donnelly SM; Stack C; Dalton JP; Mulcahy G
    Vaccine; 2010 Aug; 28(34):5551-7. PubMed ID: 20600503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins.
    Muro A; Ramajo V; López J; Simón F; Hillyer GV
    Vet Parasitol; 1997 May; 69(3-4):219-29. PubMed ID: 9195732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production.
    Abou-Elhakam H; Rabee I; El Deeb S; El Amir A
    Pak J Biol Sci; 2013 Nov; 16(22):1449-58. PubMed ID: 24511686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking Fasciola hepatica's energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase.
    Jaros S; Jaros D; Wesolowska A; Zygner W; Wedrychowicz H
    Vet Parasitol; 2010 Sep; 172(3-4):229-37. PubMed ID: 20538413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1 and Th2 cytokine gene expression in primary infection and vaccination against Fasciola gigantica in buffaloes by real-time PCR.
    Kumar N; Raina OK; Nagar G; Prakash V; Jacob SS
    Parasitol Res; 2013 Oct; 112(10):3561-8. PubMed ID: 23873619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T-cell clones obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm antigen express both unrestricted and Th2 cytokine profiles.
    Brown WC; Davis WC; Dobbelaere DA; Rice-Ficht AC
    Infect Immun; 1994 Mar; 62(3):818-27. PubMed ID: 7509319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.